Our Patents | Patented Photobiological Eyewear | Sleepaxa
Intellectual Property · Acieon Labs
Patented light science. Not borrowed. Not sourced. Ours.
Most eyewear brands buy their lenses from a catalog and add a tint. We invent ours. Sleepaxa’s technology is protected by a granted patent and a growing portfolio of filings — developed in-house at our research division, Acieon Labs.
Granted
Patent 587746 — Dual-Band Selective Light Attenuation
The technology behind NeuroCalm FLX+. An optical lens that independently attenuates two tuned wavelength bands relevant to migraine photophobia while preserving photopic luminance and colour balance. Granted — all 10 claims allowed.
The portfolio
| Invention | Protects | Status |
|---|---|---|
| Dual-band selective light attenuation | NeuroCalm FLX+ migraine lens | Granted (587746) |
| Multi-component chromophore formulation | Circadian560 sleep lens | Pending |
| Enhanced chromatic contrast lens | Colour-contrast perception | Pending |
| Spectrally differential temporal kinetics | Adaptive photochromic response | Pending |
| Adaptive biological light assessment | Light-measurement platform | Pending |
| State-dependent inter-layer optical gating | Passive adaptive lens (no electronics) | Pending |
Why this matters to you
A patent isn’t marketing — it’s a verifiable, examined claim that our technology is genuinely new. When you wear Sleepaxa, you’re wearing light science that exists nowhere else, engineered by our own researchers and documented in open, citable publications.
Meet the researchers behind the patents →
Patent filings and grants describe intellectual-property protection. They do not by themselves represent medical-device approval, clinical clearance, or any claim to diagnose, treat, cure, or prevent a condition.